AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer’s Disease-Reference-Cited by-同舟云学术

AVN-211, Novel and Highly Selective 5-HT6 Receptor Small Molecule Antagonist, for the Treatment of Alzheimer’s Disease

Published:2016-02-26 Issue:3 Volume:13 Page:945-963
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Ivachtchenko Alexandre V.¹²,Lavrovsky Yan³,Ivanenkov Yan A.⁴⁵

Affiliation:

1. Alla Chem LLC, 1835 East Hallandale Beach Boulevard, #442, Hallandale Beach, Florida 33009, United States

2. Avineuro Pharmaceuticals, Inc., 1835 East Hallandale Beach Boulevard, #442, Hallandale Beach, Florida 33009, United States

3. R-Pharm Overseas, Inc., 12526 High Bluff Drive, Suite #300, San Diego, California 92130, United States

4. Moscow Institute of Physics and Technology (State University), 9 Institutskiy Lane, Dolgoprudny City, Moscow Region 141700, Russian Federation

5. Chemistry Department, Moscow State University, Leninskie Gory, Building 1/3, GSP-1, 119991, Moscow, Russia

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.5b00830

Reference105 articles.

1. World Health Organization, http://www.who.int/en, accessed 16 July, 2015.

2. 3-(2,4-Dimethoxybenzylidene)-anabaseine: A promising candidate drug for Alzheimer's disease?

3. Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment

4. A PET Study of the Effects of p38 MAP Kinase Inhibitor, VX-745, on Amyloid Plaque Load in Alzheimer’s Disease (AD). NCT02423122,https://clinicaltrials.gov/ct2/show/NCT02423122, accessed 16 July 2015.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serotonin Receptors as a Potential Target in the Treatment of Alzheimer’s Disease;Biochemistry (Moscow);2023-12

2. Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders;Biomolecules;2023-02-07

3. Structural Scaffolds as Anti- Alzheimer Agents;Medicinal Chemistry;2023-02

4. Understanding How Physical Exercise Improves Alzheimer’s Disease: Cholinergic and Monoaminergic Systems;Frontiers in Aging Neuroscience;2022-05-18

5. In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease;Molecules;2022-04-19